Mitochondrial Myopathy News

University of Helsinki Researchers Discover Vitamin B3 Form that is Effective in Attenuating Mitochondrial Myopathy Progression

Researchers from the University of Helsinki recently found that a vitamin B3 form might be effective in attenuating the progression of mitochondrial myopathy. The study is published in the journal EMBO Molecular Medicine. Mitochondrial disorders are caused by respiratory chain deficiency (RCD) and are the most usual…

Individual Case Report Highlights Rare Acute Kidney Injury Leading To Mitochondrial Myopathy

A recent case report of a patient with acute kidney injury who was later diagnosed with mitochondrial myopathy, titled “Recurrent episodic acute kidney injury as presenting manifestation of mitochondrial myopathy,” is published in the Indian Journal of Nephrology. Mitochondrial cytopathies (MC) are a rare…

Toxins Crossing the Placental Barrier Can Lead To Mitochondrial Toxcicity, Diseases

A recent controversial decision to legalize “three parent babies” in the United Kingdom has led researchers to believe that they may have found a solution for heading off genetically transferred Mitochondrial Diseases from Mother to fetus. A new study from researchers at the Hospital Clinic of Barcelona in Spain, however,…

Stealth BioTherapeutics Initiates Clinical Study of Bendavia for the Treatment of Mitochondrial Myopathy

Stealth BioTherapeutics, a biopharmaceutical company developing treatments for rare, mitochondria-related diseases, recently announced the initiation of a new clinical study of Bendavia for the treatment of Mitochondrial Myopathy (MM). Mitochondrial Myopathy (MM) is rare genetic condition that affects the mitochondria, a cell’s “center” responsible for maintaining the body’s energy, causing progressive muscle weakness.